Zydus Wellness Schedules Q4FY26 Analyst & Investor Conference Call for May 18, 2026
Zydus Wellness Limited has scheduled a teleconference call for analysts and institutional investors on May 18, 2026, at 4:00 p.m. IST, following the announcement of audited financial results for the quarter and financial year ended March 31, 2026. Facilitated by ICICI Securities, the call will feature Dr. Sharvil Patel (Chairman), Mr. Ganesh Nayak (Non-Executive Director), Mr. Tarun Arora (CEO), and Mr. Umesh Parikh (CFO), with dial-in access available across India, Singapore, Hong Kong, UK, and USA.
*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has informed the stock exchanges of a scheduled teleconference call for analysts and institutional investors on Monday, May 18, 2026, at 4:00 p.m. IST. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to both BSE Limited and the National Stock Exchange of India Limited. The call is to be held post the announcement of audited financial results for the quarter and financial year ended March 31, 2026.
Conference Call Details
The investor interaction will be facilitated by ICICI Securities and will feature senior representatives from Zydus Wellness Limited. The following key personnel are scheduled to participate in the call:
- Dr. Sharvil Patel – Chairman
- Mr. Ganesh Nayak – Non-Executive Director
- Mr. Tarun Arora – CEO
- Mr. Umesh Parikh – CFO
Access Information
Participants may join the conference call through the following dial-in numbers:
| Region: | Dial-In Number |
|---|---|
| Universal Access (India): | +91 22 6280 1144; +91 22 7115 8045 |
| Singapore (Toll Free): | 8001012045 |
| Hong Kong (Toll Free): | 8009644448 |
| UK (Toll Free): | 08081011573 |
| USA (Toll Free): | 18667462133 |
ICICI Securities Coordinators
For any clarifications regarding the conference call, participants may reach out to the designated ICICI Securities coordinators:
| Coordinator: | Contact Details |
|---|---|
| Mr. Jaideep Goswami, Head of Equities: | jaideep.goswami@icicisecurities.com |
| Mr. Manoj Menon, Head of Research: | +91 22 6807 7209 | manoj.menon@icicisecurities.com |
| Mr. Akshay Krishnan: | +91 22 6807 7632 | akshay.krishnan@icicisecurities.com |
| Mr. Rushad Kapadia: | +91 22 6807 7334 | rushad.kapadia@icicisecurities.com |
Regulatory Compliance
The filing was submitted to the exchanges on May 9, 2026, and signed by Nandish P. Joshi, Company Secretary and Compliance Officer of Zydus Wellness Limited. The communication was addressed to the Listing Departments of both BSE Limited and the National Stock Exchange of India Limited, in accordance with applicable disclosure requirements under SEBI regulations.
What revenue growth trajectory and margin expansion can investors expect from Zydus Wellness for FY2027 given the competitive pressures in the health and wellness FMCG segment?
How might Zydus Wellness's product portfolio strategy evolve following the FY2026 results, particularly in terms of new launches or acquisitions in the premium wellness category?
Will the management provide guidance on rural market penetration and distribution expansion plans that could drive volume growth in the upcoming fiscal year?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
